• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18325
Device Problem Insufficient Information (3190)
Patient Problems Stroke/CVA (1770); Hypoglycemia (1912)
Event Date 12/26/2022
Event Type  Injury  
Manufacturer Narrative
According to the complainant the device will not be returned for investigation.We are unable to determine if any product condition could have contributed to the reported hospitalization and hyperglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms.
 
Event Description
It was reported that the patient had been hospitalized with hypoglycemia.The patient's blood glucose levels had decreased to 52 mg/dl while wearing the pod between 4 and 24 hours.The patient was admitted to the hospital due to having a stroke, while there the patient was diagnosed with hypoglycemia.The patient was given computerized tomography (ct) scan.In addition the patients pod was removed to have a magnetic resonance imaging (mri).The patient was treated with intravenous fluids and glucose.The patient received insulin injections as needed.The patient was also given lipitor and tylenol.The patient was prescribed atorvastatin calcium tab (40) to be taken once daily as well as tylenol.The patient was released from the hospital after 4 days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
michael spears
100 nagog park
acton, MA 01720
9786007000
MDR Report Key16230150
MDR Text Key307977602
Report Number3004464228-2023-01790
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385082000051
UDI-Public(01)20385082000051(11)211228(17)230628(10)PD1U12282131
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/23/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/28/2023
Device Model Number18325
Device Catalogue NumberBLE-P1-525
Device Lot NumberPD1U12282131
Was Device Available for Evaluation? No
Date Manufacturer Received01/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/28/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age84 YR
Patient SexFemale
-
-